CAD 0.04
(-20.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 232.37 Thousand CAD | -47.44% |
2022 | 442.11 Thousand CAD | -80.52% |
2021 | 2.26 Million CAD | -51.59% |
2020 | 4.68 Million CAD | 503.01% |
2019 | 777.21 Thousand CAD | 129.23% |
2018 | 339.05 Thousand CAD | -31.03% |
2017 | 491.63 Thousand CAD | 228.44% |
2016 | 149.68 Thousand CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 282.58 Thousand CAD | 21.61% |
2023 Q2 | 371.5 Thousand CAD | -14.74% |
2023 Q3 | 342.44 Thousand CAD | -7.82% |
2023 Q1 | 435.75 Thousand CAD | -1.44% |
2023 Q4 | 232.37 Thousand CAD | -32.14% |
2023 FY | 232.37 Thousand CAD | -47.44% |
2022 Q2 | 1.16 Million CAD | -36.29% |
2022 Q4 | 442.11 Thousand CAD | -44.05% |
2022 Q1 | 1.82 Million CAD | -19.68% |
2022 FY | 442.11 Thousand CAD | -80.52% |
2022 Q3 | 790.13 Thousand CAD | -31.94% |
2021 Q1 | 4.22 Million CAD | -9.95% |
2021 FY | 2.26 Million CAD | -51.59% |
2021 Q4 | 2.26 Million CAD | 42.84% |
2021 Q3 | 1.58 Million CAD | -43.61% |
2021 Q2 | 2.81 Million CAD | -33.25% |
2020 Q1 | 370.05 Thousand CAD | -52.39% |
2020 FY | 4.68 Million CAD | 503.01% |
2020 Q2 | 4.24 Million CAD | 1046.91% |
2020 Q3 | 5.13 Million CAD | 20.89% |
2020 Q4 | 4.68 Million CAD | -8.66% |
2019 Q2 | 147.75 Thousand CAD | -52.37% |
2019 FY | 777.21 Thousand CAD | 129.23% |
2019 Q4 | 777.21 Thousand CAD | 185.4% |
2019 Q3 | 272.31 Thousand CAD | 84.31% |
2019 Q1 | 310.23 Thousand CAD | -8.5% |
2018 Q1 | 550.9 Thousand CAD | 12.06% |
2018 FY | 339.05 Thousand CAD | -31.03% |
2018 Q4 | 339.05 Thousand CAD | -24.47% |
2018 Q3 | 448.91 Thousand CAD | -15.35% |
2018 Q2 | 530.28 Thousand CAD | -3.74% |
2017 Q1 | - CAD | -100.0% |
2017 Q4 | 491.63 Thousand CAD | -18.52% |
2017 FY | 491.63 Thousand CAD | 228.44% |
2017 Q3 | 603.35 Thousand CAD | -7.68% |
2017 Q2 | 653.55 Thousand CAD | 0.0% |
2016 FY | 149.68 Thousand CAD | 0.0% |
2016 Q4 | 149.68 Thousand CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
BioMark Diagnostics Inc. | 1.08 Million CAD | 78.66% |
Sona Nanotech Inc. | 2.74 Million CAD | 91.545% |